期刊文献+

Bio-Plex悬液芯片技术在生命科学与临床医学中的应用 被引量:3

下载PDF
导出
摘要 近年来,为了深入探索基因与蛋白,分子生物学技术也随之得到了长足的发展。酶联免疫吸附试验(ELISA)等技术应运而生,促进了临床医学的飞速发展。由于患者及疾病的异质性,单一因子检测的临床价值有限,比如对肿瘤检测最有价值的血清学标记物甲胎蛋白(AFP),对肝癌诊断的灵敏度不到70%,因此联合多种血清因子检测对于提高临床诊断价值尤为重要。在此基础上产生了一种高通量血清检测技术即悬液芯片技术。
出处 《重庆医学》 CAS 北大核心 2017年第25期3594-3597,共4页 Chongqing medicine
基金 重庆市社会民生科技创新专项项目(CSPC2015SHMSZX1066)
  • 相关文献

参考文献1

二级参考文献13

  • 1Toyooka S,Kiura K,Mitsudomi T. EGFR mutation and responseof lung cancer to gefitinib [ J ]. N Engl J Med,2005 ,352 ( 20 );2136.
  • 2Wu J Y,Yu C J, Chang Y C, al. Effectiveness of tyrosine ki-nase inhibitors on “Uncommon” epidermal growth factor receptormutations of unknown clinical significance in non-small cell lungcancer[J]. Clin Cancer Res, 2011 ,17(11) :3812 -21.
  • 3Gazdar A F. Activating and resistance mutations of EGFR in non-small-cell lung cancer : role in clinical response to EGFR tyrosinekinase inhibitors [J]. Oncogene,2009,28 ( Suppl 1) : S24 - 31.
  • 4Shigematsu H, Lin L, Takahashi T, et al. Clinical and biologicalfeatures associated with epidermal growth factor receptor gene mu-tations in lung cancers[ J]. J Natl Cancer Inst, 2005,97(5) :339-46.
  • 5Wu S G, Chang Y L,Lin J W, e( al. Including total EGFR stai-ning in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction[ J]. PLoSOne, 2011,6(8) :e23303.
  • 6Pirker R, Herth F J,Kerr K M, e( al. Consensus for EGFR mu-tation testing in non-small cell lung cancer: results from a Europe-an workshop[ J] . J Thorac Oncol, 2010,5( 10) :1706 -13.
  • 7Tsiatis A C, Norris-Kirby A, Rich R G, ei al. Comparison of san-ger sequencing, pyrosequencing,and melting curve analysis forthe detection of KRAS mutations .. diagnostic and clinical impiica-tions[J], J Mol Diagn, 2010,12(4) :425 -32.
  • 8Li G Q, Luo X D, He J Y, ef o/. A novel liquidchip platform forsimultaneous detection of 70 alleles of DNA somatic mutations onEGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraf-fin-embedded slides containing tumor tissue[ J]. Clin Chem LabMed, 2011,49(2) :191 -5.
  • 9Lu H Y, Sun W Y, Chen B, et al. Epidermal growth factor recep-tor mutations in small cell lung cancer patients who received surgi-cal resection in China [ J]. Neoplasma,2011,59(1):100- 4.
  • 10Xu J, He J, Yang H, et al. Somatic mutation analysis of EGFR,KRAS, BRAF and PIK3CA in 861 patients with non-small celllung cancer[J]. Cancer Biomark, 2011,10(2) :63 -9.

共引文献1

同被引文献14

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部